Puls Medycyny: 2022 is a year in which the biotech Biotts plans to invest several million PLN and introduce GMP and ISO standards. Among the company’s projects is a breakthrough transdermal system – a solution that makes it possible to transport drug molecules in doses that are several times larger than the capacity of currently available methods.
This year Biotts plans to spend as much as PLN 12 million on development. One of the key areas of focus is on an innovative technology being developed by this Wroclaw-based startup which makes it possible to deliver pharmaceuticals through the skin and makes it much easier to treat many common-place and serious diseases.
